Genome-wide oligonucleotide microarray analysis of gene-expression profiles of taiwanese patients with anaplastic astrocytoma and glioblastoma multiforme

Journal of Biomolecular Screening

Volumn 13, Issue 9, 2008, Pages 912-921

  Chang, Chia Lin ^a  

^a HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Anaplastic astrocytoma; Gene expression; Glioblastoma multiforme; Oligonucleotide microarray; Quantitative reverse transcription polymerase chain reaction

Indexed keywords

ALPHA 1B ADRENERGIC RECEPTOR; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; CADHERIN; CARBONATE DEHYDRATASE; CYCLIN DEPENDENT KINASE 2 INHIBITOR; CYCLIN DEPENDENT KINASE 4; EARLY GROWTH RESPONSE FACTOR 1; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOSYLATED HEMOGLOBIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; HEMOGLOBIN BETA CHAIN; HYPOXIA INDUCIBLE FACTOR 1BETA; NEUREXIN; NEUROGRANIN; OSTEONECTIN; POLO LIKE KINASE 2; PROTEIN KINASE C ZETA; RIBOSOME RNA; SOMATOMEDIN BINDING PROTEIN 2; STATHMIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE; UBIQUITIN THIOLESTERASE; UNINDEXED DRUG;

ADULT; AGED; APASTIC ASTROCYTOMA; ARTICLE; ASIAN; ASTROCYTOMA; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENOME ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMAGE QUALITY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

ASTROCYTOMA; BASE SEQUENCE; BRAIN NEOPLASMS; CLUSTER ANALYSIS; DNA PRIMERS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES; TAIWAN;

EID: 53649103513     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057108323908     Document Type: Article

References (30)

1. Tanwar MK, Gilbert MR, Holland EC: Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res 2002 ; 62: 4364-4368.
2. van den Boom J., Wolter M., Kuick R., Misek DE, Youkilis AS, Wechsler DS,, et al. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 2003 ; 163: 1033-1043.
3. Rickman DS, Bobek MP, Misek DE, Kuick R., Blaivas M., Kurnit DM,, et al. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 2001 ; 61: 6885-6891.
4. Brat DJ, Mapstone TB: Malignant glioma physiology: cellular response to hypoxia and its role in tumor progression. Ann Intern Med 2003 ; 138: 659-668.
5. Sterrenburg E., Turk R., Boer JM, van Ommen GB, den Dunnen JT: A common reference for cDNA microarray hybridizations. Nucleic Acids Res 2002 ; 30: e116.
6. Kleihues P., Cavenee WK: Pathology and genetics of tumors of the nervous system. In: World Health Organization Classification of Tumors. France, Lyon: IARC Press, 2000.
7. Khatri P., Draghici S., Ostermeier GC, Krawetz SA: Profiling gene expression using onto-express. Genomics 2002 ; 79: 266-270.
8. Wang H., Wang H., Shen W., Huang H., Hu L., Ramdas L.,, et al. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res 2003 ; 63: 4315-4321.
9. Golembieski WA, Rempel SA: cDNA array analysis of SPARC-modulated changes in glioma gene expression. J Neurooncol 2002 ; 60: 213-226.
10. Wang M., Wang T., Liu S., Yoshida D., Teramoto A.: The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol 2003 ; 20: 65-72.
11. Li YF, Sun HX, Wu GD, Du WN, Zuo J., Shen Y.,, et al. Protein kinase C/zeta (PRKCZ) gene is associated with type 2 diabetes in Han population of North China and analysis of its haplotypes. World J Gastroenterol 2003 ; 9: 2078-2082.
12. Anantharam V., Lehrmann E., Kanthasamy A., Yang Y., Banerjee P., Becker KG,, et al. Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease. Neurochem Int 2007 ; 50: 834-847.
13. Carter MG, Hamatani T., Sharov AA, Carmack CE, Qian Y., Aiba K.,, et al. In situ-synthesized novel microarray optimized for mouse stem cell and early developmental expression profiling. Genome Res 2003 ; 13: 1011-1021.
14. Presneau N., Shen Z., Provencher D., Mes-Masson AM, Tonin PN: Identification of novel variant, 1484delG in the 3′UTR of H3F3B, a member of the histone 3B replacement family, in ovarian tumors. Int J Oncol 2005 ; 26: 1621-1627.
15. Müller S., Kunkel P., Lamszus K., Ulbricht U., Lorente GA, Nelson AM,, et al. A role for receptor tyrosine phosphatase zeta in glioma cell migration. Oncogene 2003 ; 22: 6661-6668.
16. Tojyo I., Yamaguchi A., Nitta T., Yoshida H., Fujita S., Yoshida T.: Effect of hypoxia and interleukin-1β on expression of tenascin-C in temporomandibular joint. Oral Dis 2008 ; 14: 45-50.
17. Sis B., Saǧol O., Küpelioǧlu A., Sokmen S., Terzi C., Fuzun M.,, et al. Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma. Pathol Res Pract 2004 ; 200: 379-387.
18. Tanaka M., Yamazaki T., Araki N., Yoshikawa H., Yoshida T., Sakakura T.,, et al. Clinical significance of tenascin-C expression in osteosarcoma: tenascin-C promotes distant metastases of osteosarcoma. Int J Mol Med 2000 ; 5: 505-510.
19. Nishio T., Kawaguchi S., Yamamoto M., Iseda T., Kawasaki T., Hase T.: Tenascin-C regulates proliferation and migration of cultured astrocytes in a scratch wound assay. Neuroscience 2005 ; 132: 87-102.
20. Alvarez E., Zhou W., Witta SE, Freed CR: Characterization of the Bex gene family in humans, mice, and rats. Gene 2005 ; 357: 18-28.
21. Foltz G., Ryu GY, Yoon JG, Nelson T., Fahey J., Frakes A.,, et al. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Cancer Res 2006 ; 66: 6665-6674.
22. Guo Q., Xie J., Dang CV, Liu ET, Bishop JM: Identification of a large Myc-binding protein that contains RCC1-like repeats. Proc Natl Acad Sci U S A 1998 ; 95: 9172-9177.
23. Wink MR, Lenz G., Braganhol E., Tamajusuku AS, Schwartsmann G., Sarkis JJ,, et al. Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines. Cancer Lett 2003 ; 198: 211-218.
24. MacDonald TJ, Pollack IF, Okada H., Bhattacharya S., Lyons-Weiler J.: Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis. Methods Mol Biol 2007 ; 377: 203-222.
25. Rong Y., Hu F., Huang R., Mackman N., Horowitz JM, Jensen RL,, et al. Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res 2006 ; 66: 7067-7074.
26. Pen A., Moreno MJ, Martin J., Stanimirovic DB: Molecular markers of extracellular matrix remodeling in glioblastoma vessels: microarray study of laser-captured glioblastoma vessels. Glia 2007 ; 55: 559-572.
27. Rempel SA, Golembieski WA, Fisher JL, Maile M., Nakeff A.: SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins. J Neurooncol 2001 ; 53: 149-160.
28. Lebedeva TV, Ohashi M., Huang A., Vasconcellos S., Flesch S., Yu N.: Emerging new alleles suggest high diversity of HLA-C locus. Tissue Antigens 2005 ; 65: 101-106.
29. van den Boom J., Wolter M., Blaschke B., Knobbe CB, Reifenberger G.: Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription- polymerase chain reaction. Int J Cancer 2006 ; 19: 2330-2338.
30. Nakagawa T., Kabuto M., Kubota T., Kodera T., Sato K.: Production of amyloid beta protein precursor as a proteinase inhibitor by human astrocytic tumors. Anticancer Res 1999 ; 19: 2963-2968.